
Lenalid 25mg Capsule
Salt Composition: Lenalidomide
Expiry Date: 01/2028
Inclusive of all taxes
30 Capsule
About The Product
Blood Cell Cancers, Leukemia
Lenalid 25mg Capsule is an anti-cancer medication. It is used for the treatment of myelodysplastic syndrome and multiple myeloma. Lenalid 25mg Capsule affects the functioning of the immune system in producing more RBCs in the bone marrow, reducing the need for blood transfusions and making the patient feel better.
This medicine can be taken with or without food, but it must be taken at the same time every day regularly to increase the effectiveness of the medicine. It is important to monitor and check up on your health to prevent getting sick. Lenalid 25mg Capsule restricts the production and growth of chemical messengers, thereby stopping or slowing the growth of cancer cells in the human body.
Uses
- Multiple myeloma
- Treatment of Myelodysplastic Syndrome
Side Effects
The human body reacts differently to Lenalid 25mg Capsule. Response or undesired symptoms vary from individual to individual. Usually, they disappear with time as the body adjusts to the medicine; these side effects don't need special medical attention. Whereas if the symptoms don't disappear with time or you have severe side effects, then consult your doctor immediately.
Some of the common side effects of Lenalid 25mg Capsule are mentioned below:
- Sleepiness
- Confusion
- Tremor
- Swelling
- Respiratory disorder
- Bleeding gums
- Blood clots
- Anxiety
- Muscle pain
- Dry skin
- Constipation
- Rash
- Cough
- Nausea
- Sore throat
How To Use
Take the dose of Lenalid 25mg Capsule as per your healthcare provider’s prescription. Do not stop taking the medicine suddenly, unless your doctor tells you. This medicine is given under the strict supervision of a doctor. Do not self-administer.
Overdose is a very unusual state for this medicine because it is given under the supervision of a healthcare provider. Lenalid 25mg Capsule can be taken without food or with food. The doctor will provide emergency medical treatment. You should not break, crush, or chew the medicine; it should be swallowed as a whole.
How It Works
Lenalidomide Capsules are a thalidomide analog. It is an immunomodulatory agent.
This compound possesses immunomodulatory and antiangiogenic properties. It works to inhibit the secretion of pro-inflammatory cytokines and increases the secretion of anti-inflammatory cytokines from peripheral blood mononuclear cells.
Lenalidomide works to inhibit cell proliferation with varying effectiveness (IC50s) in some but not all cell lines. It prevents the growth of new blood vessels within the tumor.
Safety Advice
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Lenalidomide Capsules. Consult your doctor for further information.
Lenalidomide Capsules may be considered unsafe during pregnancy. Please consult your doctor in such a condition. According to some research data, taking Lenalidomide Capsules during pregnancy has shown harmful effects on the developing baby.
Lenalidomide Capsules is probably not safe if you're breastfeeding. Kindly consult your doctor before taking Lenalidomide Capsules while breastfeeding, as there are chances that it may pass to the developing baby through the breast milk of the mother.
It is advisable not to drive or operate heavy machinery after taking Lenalidomide Capsules, as you may feel dizzy.
Share your medical history with your healthcare expert in case of kidney disease before taking Lenalidomide Capsules. Patients with renal impairment must be careful while taking Lenalidomide Capsules. They may require adjustment in the dose.
Inform your doctor before starting Lenalidomide Capsules if you have liver disease to avoid any serious side effects. Patients with hepatic impairment must be careful while taking Lenalidomide Capsules. They may require adjustment in the dose.
Missed Doses
- It is advised not to miss any scheduled dosage of Lenalid 25mg capsule.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
- Take blood tests to monitor signs of blood clots or a fall in blood cell count on a regular basis.
- Intake a lot of water and fluids to keep the body hydrated. Taking the Lenalid 25mg capsule may cause dehydration.
- Avoid activity that results in bruising or blood loss, and avoid contact with people who have colds.
- Inform your healthcare expert that you're taking the Lenalid 25mg capsule if you're undergoing any emergency surgery.
- Use effective birth control methods to avoid pregnancy for 4 months before and after taking Lenalid 25mg capsule. It may affect the unborn baby and can cause rare birth abnormalities.
FAQs
Lenalidomide 10mg capsule is an anti-cancer medication, prescribed for the treatment of Multiple Myeloma and Lepra Reactions.
Reference
- Eisen T, Trefzer U, Hamilton A, Hersey P, Millward M, Knight RD, Jungnelius JU, Glaspy J. Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma. Cancer. 116(1):146-54 - https://pubmed.ncbi.nlm.nih.gov/19862820/
- Glaspy J, Atkins MB, Richards JM, Agarwala SS, O'Day S, Knight RD, Jungnelius JU, Bedikian AY. Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma. Cancer. 115(22):5228-36 - https://pubmed.ncbi.nlm.nih.gov/19728370/
- List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, Rimsza L, Heaton R, Knight R, Zeldis JB. (2024). Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med. 352(6):549-57.
- Shen Q, Gao T, Xiang J, Feng P, Liu X, Zheng L. (2024).Pharmacokinetic and bioequivalence of lenalidomide in multiple myeloma patients. Int J Clin Pharmacol Ther. 61(4):181-188 - https://pubmed.ncbi.nlm.nih.gov/36683548/
- Suzuki K, Shinagawa A, Uchida T, Taniwaki M, Hirata H, Ishizawa K, Matsue K, Ogawa Y, Shimizu T, Otsuka M, Matsumoto M, Iida S, Terui Y, Matsumura I, Ikeda T, Takezako N, Ogaki Y, Midorikawa S, Houck V, Ervin-Haynes A, Chou T. (2024). Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study. Cancer Sci. 107(5):653-8.
- V. Sanchorawala et al. (2025). A phase II trial of lenalidomide for patients with AL amyloidosis. J Clin Oncol 24, 7524-7524 - https://pubmed.ncbi.nlm.nih.gov/25974382/
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
